[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368022-105":59,"doc-detail-368022-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","hybrid-identity-and-distinct-methylation-profiles-of-incomplete-intestinal-metaplasia-in-the-stomach","Hybrid identity and distinct methylation profiles of incomplete intestinal metaplasia in the stomach","","Background Gastric intestinal metaplasia (GIM), especially the incomplete subtype (Inc IM), is linked to increased gastric cancer (GC) risk, yet its status as a true precursor lesion remains unclear. Objective Define the molecular identity, differentiation potential, and oncogenic relevance of Inc IM. Methods Spatial transcriptomics with a lineage-enriched panel profiles GIM and GC tissues; subtype-specific organoids are used for DNA methylation and chromatin accessibility, and single-cell RNA-seq evaluates differentiation. Results Inc IM shows a hybrid transcriptomic signature spanning gastric and intestinal lineages across differentiated and stem/progenitor compartments. Methylation reveals extensive intergenic hypermethylation resembling native antral mucosa, while complete IM is marked by promoter hypermethylation of tumor suppressor genes. Conclusions Inc IM is a phenotypically unstable, epigenetically deregulated metaplastic state with dual-lineage potential and molecular resemblance to GC, supporting its role as a true precursor and informing active surveillance and early intervention strategies.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hybrid-identity-and-distinct-methylation-profiles-of-incomplete-intestinal-metaplasia-in-the-stomach/368022/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hybrid-identity-and-distinct-methylation-profiles-of-incomplete-intestinal-metaplasia-in-the-stomach/368022.png","ImageObject",300,407,{"name":92,"@type":93},"OmBimo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-21","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is incomplete intestinal metaplasia (Inc IM) and why is it important?","Question",{"text":112,"@type":113},"Inc IM is a subtype of gastric intestinal metaplasia associated with higher gastric cancer risk. Its role as a true precursor lesion had been uncertain before this study.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study characterize Inc IM at the molecular and cellular levels?",{"text":117,"@type":113},"The study used spatial transcriptomics with a custom lineage-enriched panel, subtype-specific organoid models for DNA methylation and chromatin accessibility, and single-cell RNA sequencing to evaluate differentiation capacity.",{"name":119,"@type":110,"acceptedAnswer":120},"What distinguishes Inc IM from complete intestinal metaplasia (complete IM) epigenetically?",{"text":121,"@type":113},"Inc IM showed extensive intergenic hypermethylation resembling native antral mucosa. Complete IM displayed promoter hypermethylation of tumor suppressor genes and a more fully intestinalized epigenetic profile.",{"name":123,"@type":110,"acceptedAnswer":124},"What evidence supports Inc IM as a precursor to gastric cancer?",{"text":125,"@type":113},"Spatial mapping found enrichment of Inc IM-like cells in GC samples, especially within microsatellite stable tumors. The study also reports an approximately 76% association of analyzed GCs with GIM, supporting a precursor continuum from Inc IM to GC.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},368022,1790201141,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Gastroduodenal  \nOriginal research  \nHybrid identity and distinct methylation profiles of incomplete intestinal metaplasia in the stomach  \nHyesung Kim, 1 Junseong Kim,2 In Ho Jeong,3,4 Eunsun Park,5 Mira Yoo,5 Seokho Yoon,5 Donghyun Lee,3,4 Jaekyung Myung,6,7 Eunyoung Choi  ,8,9,10  \nJames R Goldenring  ,8,9,10,11 Bogun Jang  5,12  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.1136/gutjnl-2025-335793](10.1136/gutjnl-2025-335793)) .  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Bogun Jang; [bgjang9633@](bgjang9633@gmail.com)[gmail.com](bgjang9633@gmail.com)  \nReceived 5 May 2025 Accepted 4 July 2025  \n© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nTo cite: Kim H, Kim J, Jeong IH, et al. Gut Epub ahead of print: [please include Day Month Year] . doi:10.1136/ gutjnl-2025-335793  \nABSTRACT  \nBackground Gastric intestinal metaplasia (GIM), particularly the incomplete subtype (Inc IM), is strongly associated with increased gastric cancer (GC) risk. However, its role as a true precursor lesion remains uncertain.  \nObjective We aimed to delineate the molecular identity, differentiation potential and oncogenic relevance of Inc IM.  \nMethods Spatial transcriptomics using a custom lineage-enriched panel was applied to profile GIM and GC tissues. Subtype-specific GIM organoid models were developed for DNA methylation and chromatin accessibility profiling. Single-cell RNA sequencing was performed to evaluate differentiation capacity.  \nResults Spatial transcriptomics revealed that Inc  \nIM potentially originates from the deep antral gland cells and harbours a hybrid transcriptomic signature incorporating gastric, small intestinal and large intestinal lineages across both differentiated and stem/progenitor compartments. DNA methylation profiling of subtypespecific organoids showed that Inc IM exhibits extensive intergenic hypermethylation, resembling native antral mucosa. In contrast, complete subtype was marked by promoter hypermethylation of tumour suppressor genes and displayed a more fully intestinalised epigenetic profile. Organoid models recapitulated subtype-specific traits and demonstrated lineage plasticity. Spatial mapping of GC samples revealed an enrichment of Inc IM-like cells, particularly within microsatellite stable tumours. Approximately 76% of the GCs analysed were linked to GIM, while the remaining (24%) appeared tobe associated with deep antral differentiation. Conclusions Inc IM represents a phenotypically unstable and epigenetically deregulated metaplastic state with dual-lineage potential and molecular resemblance to GC. These findings establish Inc IM as a true precursor to GC and underscore the importance of active surveillance and early intervention strategies.  \nINTRODUCTION  \nGastric intestinal metaplasia (GIM) refers to the transformation of gastric epithelium into an intestinal phenotype, primarily driven by chronic inflammation caused by Helicobacter pylori (HP) infection.1 2 GIM is widely recognised as aprecancerous lesion that significantly increases the risk of developing intestinal-type gastric cancer (GC).3 Histologically, GIM is categorised into two  \n\n| WHAT IS ALREADY KNOWN ON THIS TOPIC |\n| --- |\n| ⇒ Incomplete-type gastric intestinal metaplasia (GIM) (Inc IM) is associated with a higher risk of gastric cancer (GC) development based on epidemiologic studies. However, its cellular and molecular identities, as well as molecular evidence linking it to GC, remain poorly defined.\u003Cbr>WHAT THIS STUDY ADDS |\n| ⇒ Spatial transcriptomic profiling revealed that Inc IM potentially arises from the antral basal gland\u003Cbr>cells and displays a unique hybrid gastric– intestinal transcriptional signature spanning both differentiated and stem/progenitor cell compartments. Inc","cbCainqUPShfWYoE","https://ap.wps.com/l/cbCainqUPShfWYoE","pdf",21174173,14,"English","# Abstract\n# Introduction\n## Gastric intestinal metaplasia and subtypes\n## Rationale for studying molecular identity\n# Methods (from abstract)\n## Spatial transcriptomics and organoid models\n## Methylation and chromatin accessibility profiling\n## Single-cell RNA sequencing\n# Results (from abstract)\n## Hybrid transcriptomic signature\n## Distinct methylation patterns\n## Enrichment of Inc IM-like cells in GC","[{\"question\":\"What is incomplete intestinal metaplasia (Inc IM) and why is it important?\",\"answer\":\"Inc IM is a subtype of gastric intestinal metaplasia associated with higher gastric cancer risk. Its role as a true precursor lesion had been uncertain before this study.\"},{\"question\":\"How did the study characterize Inc IM at the molecular and cellular levels?\",\"answer\":\"The study used spatial transcriptomics with a custom lineage-enriched panel, subtype-specific organoid models for DNA methylation and chromatin accessibility, and single-cell RNA sequencing to evaluate differentiation capacity.\"},{\"question\":\"What distinguishes Inc IM from complete intestinal metaplasia (complete IM) epigenetically?\",\"answer\":\"Inc IM showed extensive intergenic hypermethylation resembling native antral mucosa. Complete IM displayed promoter hypermethylation of tumor suppressor genes and a more fully intestinalized epigenetic profile.\"},{\"question\":\"What evidence supports Inc IM as a precursor to gastric cancer?\",\"answer\":\"Spatial mapping found enrichment of Inc IM-like cells in GC samples, especially within microsatellite stable tumors. The study also reports an approximately 76% association of analyzed GCs with GIM, supporting a precursor continuum from Inc IM to GC.\"}]","Hybrid identity and distinct methylation profiles of incomplete intestinal metaplasia in the stomach | PDF",1790174417,35,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2c57f0a4d10370720a33c42eafe7842.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf857cf265b1b1d5020ab2e02bfdf960.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/babb6f8fc1c796c77ea1615e064beb70.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb169b1881941c49b4f106208c59459a.webp",980,1306]